Chemotherapy in patients who fail radiotherapy for diffuse aggressive non-hodgkin's lymphoma

James Olen Armitage, B. Chen Wen

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Twenty patients with diffuse aggressive non-Hodgkin's lymphoma were treated primarily with radiotherapy for localized disease and had subsequent disease progression. All 20 patients then received an adriamycin based, combination chemotherapy regimen, but only seven patients (35%) achieved a complete remission, and only four patients (20%) currently remain in remission. When 15 patients treated with the CHOP regimen were compared to 62 patients treated with CHOP during the same time period but who did not have preceding radiotherapy, patients with previous radiotherapy had a lower complete remission rate (i.e. 66% versus 33%) and a slightly lower 5-year survival rate (i.e. 41% versus 20%). Thus, unlike patients with Hodgkin's disease, patients with diffuse aggressive non-Hodgkin's lymphomas who fail radiotherapy for localized disease might not have an especially good outlook with subsequent chemotherapy.

Original languageEnglish (US)
Pages (from-to)1351-1354
Number of pages4
JournalInternational Journal of Radiation Oncology, Biology, Physics
Volume13
Issue number9
DOIs
StatePublished - Jan 1 1987

Fingerprint

chemotherapy
Non-Hodgkin's Lymphoma
radiation therapy
Radiotherapy
Drug Therapy
Combination Drug Therapy
Hodgkin Disease
progressions
Doxorubicin
Disease Progression
Survival Rate

Keywords

  • Combination chemotherapy
  • Large cell lymphoma
  • Non-Hodgkin's lymphoma

ASJC Scopus subject areas

  • Oncology
  • Radiology Nuclear Medicine and imaging
  • Radiation

Cite this

Chemotherapy in patients who fail radiotherapy for diffuse aggressive non-hodgkin's lymphoma. / Armitage, James Olen; Wen, B. Chen.

In: International Journal of Radiation Oncology, Biology, Physics, Vol. 13, No. 9, 01.01.1987, p. 1351-1354.

Research output: Contribution to journalArticle

@article{ffa1a46db5bf413a93d86029177fec80,
title = "Chemotherapy in patients who fail radiotherapy for diffuse aggressive non-hodgkin's lymphoma",
abstract = "Twenty patients with diffuse aggressive non-Hodgkin's lymphoma were treated primarily with radiotherapy for localized disease and had subsequent disease progression. All 20 patients then received an adriamycin based, combination chemotherapy regimen, but only seven patients (35{\%}) achieved a complete remission, and only four patients (20{\%}) currently remain in remission. When 15 patients treated with the CHOP regimen were compared to 62 patients treated with CHOP during the same time period but who did not have preceding radiotherapy, patients with previous radiotherapy had a lower complete remission rate (i.e. 66{\%} versus 33{\%}) and a slightly lower 5-year survival rate (i.e. 41{\%} versus 20{\%}). Thus, unlike patients with Hodgkin's disease, patients with diffuse aggressive non-Hodgkin's lymphomas who fail radiotherapy for localized disease might not have an especially good outlook with subsequent chemotherapy.",
keywords = "Combination chemotherapy, Large cell lymphoma, Non-Hodgkin's lymphoma",
author = "Armitage, {James Olen} and Wen, {B. Chen}",
year = "1987",
month = "1",
day = "1",
doi = "10.1016/0360-3016(87)90228-8",
language = "English (US)",
volume = "13",
pages = "1351--1354",
journal = "International Journal of Radiation Oncology Biology Physics",
issn = "0360-3016",
publisher = "Elsevier Inc.",
number = "9",

}

TY - JOUR

T1 - Chemotherapy in patients who fail radiotherapy for diffuse aggressive non-hodgkin's lymphoma

AU - Armitage, James Olen

AU - Wen, B. Chen

PY - 1987/1/1

Y1 - 1987/1/1

N2 - Twenty patients with diffuse aggressive non-Hodgkin's lymphoma were treated primarily with radiotherapy for localized disease and had subsequent disease progression. All 20 patients then received an adriamycin based, combination chemotherapy regimen, but only seven patients (35%) achieved a complete remission, and only four patients (20%) currently remain in remission. When 15 patients treated with the CHOP regimen were compared to 62 patients treated with CHOP during the same time period but who did not have preceding radiotherapy, patients with previous radiotherapy had a lower complete remission rate (i.e. 66% versus 33%) and a slightly lower 5-year survival rate (i.e. 41% versus 20%). Thus, unlike patients with Hodgkin's disease, patients with diffuse aggressive non-Hodgkin's lymphomas who fail radiotherapy for localized disease might not have an especially good outlook with subsequent chemotherapy.

AB - Twenty patients with diffuse aggressive non-Hodgkin's lymphoma were treated primarily with radiotherapy for localized disease and had subsequent disease progression. All 20 patients then received an adriamycin based, combination chemotherapy regimen, but only seven patients (35%) achieved a complete remission, and only four patients (20%) currently remain in remission. When 15 patients treated with the CHOP regimen were compared to 62 patients treated with CHOP during the same time period but who did not have preceding radiotherapy, patients with previous radiotherapy had a lower complete remission rate (i.e. 66% versus 33%) and a slightly lower 5-year survival rate (i.e. 41% versus 20%). Thus, unlike patients with Hodgkin's disease, patients with diffuse aggressive non-Hodgkin's lymphomas who fail radiotherapy for localized disease might not have an especially good outlook with subsequent chemotherapy.

KW - Combination chemotherapy

KW - Large cell lymphoma

KW - Non-Hodgkin's lymphoma

UR - http://www.scopus.com/inward/record.url?scp=0023268962&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023268962&partnerID=8YFLogxK

U2 - 10.1016/0360-3016(87)90228-8

DO - 10.1016/0360-3016(87)90228-8

M3 - Article

VL - 13

SP - 1351

EP - 1354

JO - International Journal of Radiation Oncology Biology Physics

JF - International Journal of Radiation Oncology Biology Physics

SN - 0360-3016

IS - 9

ER -